Logo image of SEAT

VIVID SEATS INC - CLASS A (SEAT) Stock Fundamental Analysis

NASDAQ:SEAT - Nasdaq - US92854T1007 - Common Stock - Currency: USD

1.63  -0.07 (-4.12%)

After market: 1.6225 -0.01 (-0.46%)

Fundamental Rating

2

Overall SEAT gets a fundamental rating of 2 out of 10. We evaluated SEAT against 72 industry peers in the Entertainment industry. SEAT has a medium profitability rating, but doesn't score so well on its financial health evaluation. SEAT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year SEAT has reported negative net income.
SEAT had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SEAT reported negative net income in multiple years.
Of the past 5 years SEAT 4 years had a positive operating cash flow.
SEAT Yearly Net Income VS EBIT VS OCF VS FCFSEAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.16%, SEAT is in the better half of the industry, outperforming 63.89% of the companies in the same industry.
SEAT's Return On Equity of -0.68% is fine compared to the rest of the industry. SEAT outperforms 68.06% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.91%, SEAT is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SEAT is significantly below the industry average of 23.07%.
Industry RankSector Rank
ROA -0.16%
ROE -0.68%
ROIC 0.91%
ROA(3y)2.63%
ROA(5y)-11.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.46%
ROIC(5y)N/A
SEAT Yearly ROA, ROE, ROICSEAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

The Operating Margin of SEAT (2.30%) is better than 63.89% of its industry peers.
SEAT's Operating Margin has declined in the last couple of years.
The Gross Margin of SEAT (73.72%) is better than 87.50% of its industry peers.
SEAT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.3%
PM (TTM) N/A
GM 73.72%
OM growth 3Y-31.94%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.39%
GM growth 5Y-0.9%
SEAT Yearly Profit, Operating, Gross MarginsSEAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SEAT is destroying value.
Compared to 1 year ago, SEAT has less shares outstanding
The number of shares outstanding for SEAT has been increased compared to 5 years ago.
SEAT has a worse debt/assets ratio than last year.
SEAT Yearly Shares OutstandingSEAT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
SEAT Yearly Total Debt VS Total AssetsSEAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

SEAT has an Altman-Z score of -0.22. This is a bad value and indicates that SEAT is not financially healthy and even has some risk of bankruptcy.
SEAT has a worse Altman-Z score (-0.22) than 68.06% of its industry peers.
SEAT has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.01, SEAT is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Altman-Z -0.22
ROIC/WACC0.13
WACC6.82%
SEAT Yearly LT Debt VS Equity VS FCFSEAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M

2.3 Liquidity

SEAT has a Current Ratio of 0.77. This is a bad value and indicates that SEAT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.77, SEAT is doing worse than 61.11% of the companies in the same industry.
A Quick Ratio of 0.70 indicates that SEAT may have some problems paying its short term obligations.
SEAT has a worse Quick ratio (0.70) than 61.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.7
SEAT Yearly Current Assets VS Current LiabilitesSEAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

SEAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -99.25%.
Looking at the last year, SEAT shows a small growth in Revenue. The Revenue has grown by 0.82% in the last year.
SEAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.59% yearly.
EPS 1Y (TTM)-99.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-160%
Revenue 1Y (TTM)0.82%
Revenue growth 3Y20.52%
Revenue growth 5Y10.59%
Sales Q2Q%-13.94%

3.2 Future

The Earnings Per Share is expected to grow by 52.40% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.22% on average over the next years.
EPS Next Y-273.77%
EPS Next 2Y-56.41%
EPS Next 3Y-3.34%
EPS Next 5Y52.4%
Revenue Next Year-16.77%
Revenue Next 2Y-6.78%
Revenue Next 3Y-1.11%
Revenue Next 5Y2.22%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SEAT Yearly Revenue VS EstimatesSEAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
SEAT Yearly EPS VS EstimatesSEAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.2 0.4 0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Forward Price/Earnings Ratio is negative for SEAT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEAT Price Earnings VS Forward Price EarningsSEAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

81.94% of the companies in the same industry are more expensive than SEAT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.63
SEAT Per share dataSEAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

A cheap valuation may be justified as SEAT's earnings are expected to decrease with -3.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-56.41%
EPS Next 3Y-3.34%

More info and screens

0

5. Dividend

5.1 Amount

SEAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VIVID SEATS INC - CLASS A

NASDAQ:SEAT (7/18/2025, 8:11:38 PM)

After market: 1.6225 -0.01 (-0.46%)

1.63

-0.07 (-4.12%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-12 2025-08-12/bmo
Inst Owners86.01%
Inst Owner Change0%
Ins Owners9.33%
Ins Owner Change1.43%
Market Cap335.89M
Analysts75.56
Price Target3.14 (92.64%)
Short Float %8.33%
Short Ratio4.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-291.46%
Min EPS beat(2)-472.49%
Max EPS beat(2)-110.44%
EPS beat(4)1
Avg EPS beat(4)-158.04%
Min EPS beat(4)-472.49%
Max EPS beat(4)66.52%
EPS beat(8)4
Avg EPS beat(8)-22.93%
EPS beat(12)7
Avg EPS beat(12)-0.76%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.18%
Min Revenue beat(2)-5.24%
Max Revenue beat(2)0.87%
Revenue beat(4)1
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-5.24%
Max Revenue beat(4)0.87%
Revenue beat(8)5
Avg Revenue beat(8)4%
Revenue beat(12)9
Avg Revenue beat(12)6.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-36.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2322.5%
EPS NY rev (1m)-586.95%
EPS NY rev (3m)-209.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-14%
Revenue NY rev (1m)-1.54%
Revenue NY rev (3m)-15.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 0.88
P/tB N/A
EV/EBITDA 8.63
EPS(TTM)0
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS3.63
BVpS1.85
TBVpS-3.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.16%
ROE -0.68%
ROCE 1.45%
ROIC 0.91%
ROICexc 1.1%
ROICexgc N/A
OM 2.3%
PM (TTM) N/A
GM 73.72%
FCFM N/A
ROA(3y)2.63%
ROA(5y)-11.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.46%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.08%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-37.79%
ROICexc growth 5YN/A
OM growth 3Y-31.94%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.39%
GM growth 5Y-0.9%
F-Score2
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Debt/EBITDA 6.16
Cap/Depr 15.87%
Cap/Sales 0.96%
Interest Coverage 0.81
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.7
Altman-Z -0.22
F-Score2
WACC6.82%
ROIC/WACC0.13
Cap/Depr(3y)22.81%
Cap/Depr(5y)24.24%
Cap/Sales(3y)0.5%
Cap/Sales(5y)0.53%
Profit Quality(3y)249.59%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-160%
EPS Next Y-273.77%
EPS Next 2Y-56.41%
EPS Next 3Y-3.34%
EPS Next 5Y52.4%
Revenue 1Y (TTM)0.82%
Revenue growth 3Y20.52%
Revenue growth 5Y10.59%
Sales Q2Q%-13.94%
Revenue Next Year-16.77%
Revenue Next 2Y-6.78%
Revenue Next 3Y-1.11%
Revenue Next 5Y2.22%
EBIT growth 1Y-74.83%
EBIT growth 3Y-17.97%
EBIT growth 5YN/A
EBIT Next Year63.54%
EBIT Next 3Y30.3%
EBIT Next 5Y25.07%
FCF growth 1Y-133.84%
FCF growth 3Y-34.7%
FCF growth 5Y-8.36%
OCF growth 1Y-118.8%
OCF growth 3Y-32.56%
OCF growth 5Y-6.76%